
In advanced cancer, the prevalence of fatigue is high and can be related to treatment or zzso zzso zzso zzso is a central nervous system stimulant that has been used to zzso zzso There is no standard dose for MPH when used for this zzso recommended doses range from zzso + zzso 

To identify a dose to test formally in a subsequent zzso trial of fatigue, we recruited patients with advanced cancer and a fatigue score of 4 or more on a zzso zzso Following a zzso baseline assessment, each patient zzso MPH at doses ranging from 5 zzso to 15 zzso twice daily at zzso zzso In a daily diary, patients recorded measures of fatigue, depression, zzso and symptom zzso 

Ten patients provided zzso 9 completed 8 days and 5 received maximum dose at day zzso Three patients were unwilling to increase the dose to maximum levels as they were satisfied with the response at a lower zzso Across all patients, there was a pattern of rapidly improving fatigue and depression scores to day 9 (5 zzso twice daily), with minimal improvement zzso 

The results indicate a dose of 5 zzso twice daily for the definitive zzso There was little correlation between performance status and maximum tolerated zzso No patient withdrew because of zzso 

